Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Core LaboratoriesMEX:CLB 59 Debt-to-Equity is 0.62 as of Mar. 2026, which is 59% below its 10-year median of 1.50. GuruFocus rates MEX:CLB with a GF Score™ of 59/100 and a GF Value™ of MXN1,314.29. The stock has 3 warning signs investors should review. Among 795 Oil & Gas companies, Core Laboratories ranks worse than 57.99% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Core Laboratories's Debt-to-Equity or its related term are showing as below:
MEX:CLB'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.62 Med: 1.5 Max: 5.73
Current: 0.62
During the past 13 years, the highest Debt-to-Equity Ratio of Core Laboratories was 5.73. The lowest was 0.62. And the median was 1.50.
MEX:CLB's Debt-to-Equity is ranked worse than 57.99% of 795
companies
in the Oil & Gas industry
Industry Median: 0.46
vs MEX:CLB: 0.62
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Core Laboratories Debt-to-Equity Related Terms
Core Laboratories Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Core Laboratories's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:CLB vs EROK, OIS, NGS: Debt-to-Equity Comparison
For the Oil & Gas Equipment & Services subindustry, Core Laboratories's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Core Laboratories Debt-to-Equity vs Oil & Gas Industry
For the Oil & Gas industry and Energy sector, Core Laboratories's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Core Laboratories's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Core Laboratories (MEX:CLB) has a Debt-to-Equity of 0.62 as of Mar. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Core Laboratories and its competitors. This is 59% below median its historical median of 1.50. Over the past decade, Core Laboratories' Debt-to-Equity has ranged from 0.62 to 5.73. According to the industry distribution chart, Core Laboratories ranks #461 out of 795 companies in the Oil & Gas industry, placing it in the top 58%.
Is Core Laboratories' Debt-to-Equity too high?
Core Laboratories' current Debt-to-Equity of 0.62 is 59% below median its 10-year median of 1.50. Over the past 10 years, this metric has ranged from a low of 0.62 to a high of 5.73. The Oil & Gas industry median Debt-to-Equity is 0.46. Core Laboratories' value of 0.62 is 34.8% above this industry median. Based on the distribution chart, Core Laboratories ranks #461 out of 795 companies in the Oil & Gas industry, which is below the industry midpoint. Overall, Core Laboratories has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does Core Laboratories' Debt-to-Equity compare to EROK and OIS?
According to the Oil & Gas industry distribution chart, Core Laboratories ranks #461 out of 795 companies for Debt-to-Equity. This places Core Laboratories in the lower half of its industry. The industry median Debt-to-Equity is 0.46. Core Laboratories' value of 0.62 is 34.8% above this benchmark. Historically, Core Laboratories' own Debt-to-Equity has ranged from 0.62 to 5.73 over the past decade. While the company's 10-year median is 1.50 vs. the industry median of 0.46, Core Laboratories has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for an Oil & Gas company?
The median Debt-to-Equity among Oil & Gas companies is 0.46, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Core Laboratories's current Debt-to-Equity of 0.62 is 34.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Core Laboratories and its competitors. For the Oil & Gas industry, the median Debt-to-Equity is 0.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Core Laboratories's current Debt-to-Equity is 0.62, which is 59% below median its own 10-year median of 1.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Core Laboratories stock overvalued right now?
Core Laboratories (MEX:CLB) has a current Debt-to-Equity of 0.62. The stock's GF Value™ is MXN1,314.29, compared to a current price of MXN856.38 — trading 34.8% below its estimated fair value. The current Debt-to-Equity is 0.62, which is 59% below median its 10-year median of 1.50 and 34.8% above the Oil & Gas industry median of 0.46. Core Laboratories' overall GF Score™ is 59/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Core Laboratories (MEX:CLB), the current Debt-to-Equity is 0.62 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Core Laboratories (MEX:CLB) Overvalued in 2026?
Based on GuruFocus' analysis, Core Laboratories stock appears to be undervalued.
The current stock price of MXN856.38 is trading 34.8% below its estimated GF Value™ of MXN1,314.29.
Key valuation signals for MEX:CLB:
Debt-to-Equity: 0.62 (59% below median its 10-year median of 1.50)
GF Value™: MXN1,314.29 vs. price of MXN856.38 (34.8% below fair value)
Industry Position: 34.8% above the Oil & Gas median (#461 of 795)
No single metric tells the full story. See the MEX:CLB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Core Laboratories Inc is a providers of proprietary and patented reservoir description and production enhancement services and products to the oil and gas industry, through client relationships. The company operates its business in two segments; Reservoir Description, and Production Enhancement. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services. The company generates majority of its revenue from Reservoir Description segment.
59GF Score
Get the complete analysis for MEX:CLB
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:CLB has been successfully added to your 
